Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Qu & Co. Chemistry B V holds a company patent portfolio focused on Biotechnology & Pharmaceuticals. The data shows 1 pending office action for the portfolio. This matter is being reviewed by 1 distinct examiner, indicating that the company's current prosecution efforts are concentrated under a single point of oversight. The portfolio is active within 1 distinct art unit, reflecting a specific technical focus for the pending claims.
HAYES, JONATHAN EDWARD is the busiest examiner for the company, with 1 busiest examiner pending office action. This action constitutes the entirety of the 1 pending office action currently active for the portfolio. For a patent practitioner, this means that the prosecution strategy must be tailored specifically to the preferences and history of this one examiner. The lack of diversity in examiners and art units suggests a very targeted intellectual property strategy.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HAYES, JONATHAN EDWARD | 1 | 36.3% | +23.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17777730 | EFFICIENT QUANTUM CHEMISTRY SIMULATION USING GATE-BASED QUBIT QUANTUM DEVICES | HAYES, JONATHAN EDWARD | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17777730 | EFFICIENT QUANTUM CHEMISTRY SIMULATION USING GATE-BASED QUBIT QUANTUM DEVICES | HAYES, JONATHAN EDWARD | — |
| Art Unit | Apps |
|---|---|
| 1685 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17777730 | EFFICIENT QUANTUM CHEMISTRY SIMULATION USING GATE-BASED QUBIT QUANTUM DEVICES | HAYES, JONATHAN EDWARD | 1685 | §103§112 | Final Rejection | — | Pending | May 18, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialQu & Co. Chemistry B V has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Jonathan Edward Hayes has the most, with 1 of Qu & Co. Chemistry B V's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
